Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
INDUSTRY
×
Carcinoma
×
Mitomycin
×
Clear all
Filters
3
NCT05874921
2025-02-28
uTRACT
UroGen Pharma Ltd.
Recruiting
400 enrolled
NCT02793128
2020-12-22
Olympus
UroGen Pharma Ltd.
Phase 3
Completed
71 enrolled
16 charts
2 FDA
NCT04006691
2020-05-07
Retreatment
UroGen Pharma Ltd.
Phase 3
Withdrawn